GOSS
Price:
$0.168
Market Cap:
$39.40M
Gossamer Bio, Inc. operates as a U.S.-based, clinical-stage biopharmaceutical company. Its primary objective is to discover, acquire, advance, and market novel therapeutic solutions, specifically addressing conditions within immunology, inflammatory diseases, and oncology. The company's pipeline highlights several key drug candidates: GB002: An inhaled small molecule designed to inhibit platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R), and c-KIT, currently being developed for pulmonary arterial hypertension. GB004: An oral, gut-targeted small molecule in development for treating inflammatory bowel disease. GB5121: An oral, irreversible covalent sm...[Read more]
Industry
Biotechnology
IPO Date
2019-02-08
Stock Exchange
NASDAQ
Ticker
GOSS
According to Gossamer Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is 174.85%. This represents a change of 234.72% compared to the average of 52.24% of the last 4 quarters.
The mean historical ROE of Gossamer Bio, Inc. over the last ten years is -226.99%. The current 174.85% ROE has changed -177.03% with respect to the historical average. Over the past ten years (40 quarters), GOSS's ROE was at its highest in in the March 2025 quarter at 586.21%. The ROE was at its lowest in in the December 2022 quarter at -461.74%.
Average
-226.99%
Median
-63.59%
Minimum
-1899.30%
Maximum
138.78%
Discovering the peaks and valleys of Gossamer Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 885.86%
Maximum Annual ROE = 138.78%
Minimum Annual Increase = -172.41%
Minimum Annual ROE = -1899.30%
| Year | ROE | Change |
|---|---|---|
| 2025 | 138.78% | -172.41% |
| 2024 | -191.67% | -33.09% |
| 2023 | -286.47% | -84.92% |
| 2022 | -1899.30% | 885.86% |
| 2021 | -192.65% | 153.87% |
| 2020 | -75.89% | 47.93% |
| 2019 | -51.30% | -141.91% |
| 2018 | 122.40% | 24.05% |
| 2017 | 98.67% | 46.23% |
The current ROE of Gossamer Bio, Inc. (GOSS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-113.12%
5-year avg
-486.26%
10-year avg
-226.99%
Gossamer Bio, Inc.’s ROE is greater than KalVista Pharmaceuticals, Inc. (-1057.44%), greater than 4D Molecular Therapeutics, Inc. (-36.83%), greater than Olema Pharmaceuticals, Inc. (-45.95%), greater than Ventyx Biosciences, Inc. (-48.11%), greater than Lexicon Pharmaceuticals, Inc. (-18.64%), less than Rigel Pharmaceuticals, Inc. (147.03%), greater than Prothena Corporation plc (-49.88%), greater than Corvus Pharmaceuticals, Inc. (-38.92%), greater than RAPT Therapeutics, Inc. (-61.81%), greater than REGENXBIO Inc. (-232.50%),
| Company | ROE | Market cap |
|---|---|---|
| -1057.44% | $1.44B | |
| -36.83% | $504.99M | |
| -45.95% | $830.67M | |
| -48.11% | $1.00B | |
| -18.64% | $892.83M | |
| 147.03% | $608.90M | |
| -49.88% | $467.51M | |
| -38.92% | $1.00B | |
| -61.81% | $959.26M | |
| -232.50% | $403.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gossamer Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gossamer Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Gossamer Bio, Inc.'s ROE?
How is the ROE calculated for Gossamer Bio, Inc. (GOSS)?
What is the highest ROE for Gossamer Bio, Inc. (GOSS)?
What is the 3-year average ROE for Gossamer Bio, Inc. (GOSS)?
What is the 5-year average ROE for Gossamer Bio, Inc. (GOSS)?
How does the current ROE for Gossamer Bio, Inc. (GOSS) compare to its historical average?